Cargando…

Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review

The present study aimed to review the existing literature and to evaluate the best dose regimen for benznidazole in adult patients with Chagas disease in the chronic phase. A systematic review was conducted followed by meta-analysis. Searches were performed in four databases, to include studies publ...

Descripción completa

Detalles Bibliográficos
Autores principales: Frade, Virgínia Paula, Simões, Nathália Soares, Couto, Nayara Ragi Baldoni, Sanches, Cristina, Oliveira, Cláudia Di Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto de Medicina Tropical 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384592/
https://www.ncbi.nlm.nih.gov/pubmed/32725057
http://dx.doi.org/10.1590/S1678-9946202062052
_version_ 1783563632466984960
author Frade, Virgínia Paula
Simões, Nathália Soares
Couto, Nayara Ragi Baldoni
Sanches, Cristina
Oliveira, Cláudia Di Lorenzo
author_facet Frade, Virgínia Paula
Simões, Nathália Soares
Couto, Nayara Ragi Baldoni
Sanches, Cristina
Oliveira, Cláudia Di Lorenzo
author_sort Frade, Virgínia Paula
collection PubMed
description The present study aimed to review the existing literature and to evaluate the best dose regimen for benznidazole in adult patients with Chagas disease in the chronic phase. A systematic review was conducted followed by meta-analysis. Searches were performed in four databases, to include studies published until May 2019. The descriptors used were: “Chagas disease”, “benznidazole”, “Drug Therapy”, “Pharmacokinetics”, “Dose-response relationship, drug” and “Chronic disease”. The meta-analysis compared studies using the standard dose of 5 mg/kg/day for 30 or 60 days. A total of 608 articles were found, 23 of which were considered eligible for this review and nine were included in the meta-analysis. The studies selected and analyzed were published between 1996 and 2018, with various benznidazole dose regimens, ranging from 2.5 mg/kg/day to 10 mg/kg/day, for 30 to 80 days of treatment. The results pointed to a great diversity of dose regimens, thus there is no consensus on the optimal dose regimen for benznidazole in the chronic phase of Chagas disease.
format Online
Article
Text
id pubmed-7384592
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Instituto de Medicina Tropical
record_format MEDLINE/PubMed
spelling pubmed-73845922020-08-03 Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review Frade, Virgínia Paula Simões, Nathália Soares Couto, Nayara Ragi Baldoni Sanches, Cristina Oliveira, Cláudia Di Lorenzo Rev Inst Med Trop Sao Paulo Review The present study aimed to review the existing literature and to evaluate the best dose regimen for benznidazole in adult patients with Chagas disease in the chronic phase. A systematic review was conducted followed by meta-analysis. Searches were performed in four databases, to include studies published until May 2019. The descriptors used were: “Chagas disease”, “benznidazole”, “Drug Therapy”, “Pharmacokinetics”, “Dose-response relationship, drug” and “Chronic disease”. The meta-analysis compared studies using the standard dose of 5 mg/kg/day for 30 or 60 days. A total of 608 articles were found, 23 of which were considered eligible for this review and nine were included in the meta-analysis. The studies selected and analyzed were published between 1996 and 2018, with various benznidazole dose regimens, ranging from 2.5 mg/kg/day to 10 mg/kg/day, for 30 to 80 days of treatment. The results pointed to a great diversity of dose regimens, thus there is no consensus on the optimal dose regimen for benznidazole in the chronic phase of Chagas disease. Instituto de Medicina Tropical 2020-07-24 /pmc/articles/PMC7384592/ /pubmed/32725057 http://dx.doi.org/10.1590/S1678-9946202062052 Text en https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Frade, Virgínia Paula
Simões, Nathália Soares
Couto, Nayara Ragi Baldoni
Sanches, Cristina
Oliveira, Cláudia Di Lorenzo
Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review
title Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review
title_full Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review
title_fullStr Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review
title_full_unstemmed Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review
title_short Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review
title_sort ideal benznidazole dose regimen in chronic chagasic patients: a systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384592/
https://www.ncbi.nlm.nih.gov/pubmed/32725057
http://dx.doi.org/10.1590/S1678-9946202062052
work_keys_str_mv AT fradevirginiapaula idealbenznidazoledoseregimeninchronicchagasicpatientsasystematicreview
AT simoesnathaliasoares idealbenznidazoledoseregimeninchronicchagasicpatientsasystematicreview
AT coutonayararagibaldoni idealbenznidazoledoseregimeninchronicchagasicpatientsasystematicreview
AT sanchescristina idealbenznidazoledoseregimeninchronicchagasicpatientsasystematicreview
AT oliveiraclaudiadilorenzo idealbenznidazoledoseregimeninchronicchagasicpatientsasystematicreview